UPDATE: GoodRx (GDRX) PT Lowered to $5.50 at Wells, 'Growth Acceleration Mainly Hinges on Pharma Ad Segment That Is Seeing Material N-T Headwinds'
Tweet Send to a Friend
(Updated - November 9, 2022 4:12 PM EST)
Wells Fargo analyst Stan Berenshteyn lowered the price target on GoodRx ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wells Fargo analyst Stan Berenshteyn lowered the price target on GoodRx ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
